Allmed Medical Products Co.,Ltd (SHE:002950)
China · Delayed Price · Currency is CNY 12.01
0.00 (0.00%)
Jan 23, 2026, 3:04 PM CST
SHE:002950 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | 452.32 | 368.68 | 110.4 | 406.79 | 431.21 | 1,158 | Upgrade |
Depreciation & Amortization | 232.29 | 232.29 | 227.38 | 193.2 | 147.21 | 142.22 | Upgrade |
Other Amortization | 0.01 | 0.01 | 2.49 | 1.56 | 0.72 | 0.39 | Upgrade |
Loss (Gain) From Sale of Assets | -28.79 | -28.79 | 0.07 | -3.5 | -1.94 | -26.34 | Upgrade |
Asset Writedown & Restructuring Costs | 9.14 | 9.14 | -0.5 | 23.24 | 4.18 | 0.08 | Upgrade |
Loss (Gain) From Sale of Investments | 23.28 | 23.28 | 6.88 | 160.19 | -41.93 | -44.61 | Upgrade |
Provision & Write-off of Bad Debts | 2.9 | 2.9 | -0.31 | 1.7 | 3.18 | 1.35 | Upgrade |
Other Operating Activities | -14.18 | 34.85 | 143.9 | 173.98 | -15.11 | -18.34 | Upgrade |
Change in Accounts Receivable | -52.27 | -52.27 | 157.56 | -18.06 | 75.81 | 64.96 | Upgrade |
Change in Inventory | 151.35 | 151.35 | 71.09 | -37.14 | -143.41 | 18.49 | Upgrade |
Change in Accounts Payable | -53.16 | -53.16 | -244.71 | 162.03 | -111.76 | 84.37 | Upgrade |
Operating Cash Flow | 746.26 | 711.64 | 423.5 | 1,150 | 374.85 | 1,437 | Upgrade |
Operating Cash Flow Growth | 55.16% | 68.04% | -63.17% | 206.71% | -73.91% | 426.02% | Upgrade |
Capital Expenditures | -180.3 | -157 | -286.48 | -398.05 | -290.7 | -243.28 | Upgrade |
Sale of Property, Plant & Equipment | -0 | 9.01 | 0.77 | 3.64 | 7.14 | 85.76 | Upgrade |
Cash Acquisitions | -2.4 | - | - | -99.07 | -90.83 | - | Upgrade |
Divestitures | -0.01 | - | - | - | - | - | Upgrade |
Investment in Securities | -79.39 | -1.27 | 139.45 | -475.05 | -98.84 | -620.73 | Upgrade |
Other Investing Activities | 4.7 | 4.6 | -69.21 | -1.99 | 0.11 | 33.43 | Upgrade |
Investing Cash Flow | -257.4 | -144.66 | -215.46 | -970.52 | -473.12 | -744.82 | Upgrade |
Short-Term Debt Issued | - | 339 | 180 | 381.91 | - | - | Upgrade |
Long-Term Debt Issued | - | 616.06 | 1,362 | 2,526 | 3,228 | 1,538 | Upgrade |
Total Debt Issued | 1,121 | 955.06 | 1,542 | 2,908 | 3,228 | 1,538 | Upgrade |
Short-Term Debt Repaid | - | -330 | -300.75 | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -875.8 | -1,525 | -2,976 | -3,184 | -914.52 | Upgrade |
Total Debt Repaid | -1,499 | -1,206 | -1,826 | -2,976 | -3,184 | -914.52 | Upgrade |
Net Debt Issued (Repaid) | -377.46 | -250.74 | -283.52 | -67.51 | 44.41 | 623.19 | Upgrade |
Issuance of Common Stock | - | 0.6 | - | - | - | - | Upgrade |
Repurchase of Common Stock | -97.89 | -97.89 | - | - | - | - | Upgrade |
Common Dividends Paid | -57.18 | -44.11 | -65.21 | -163.9 | -577.16 | -266.5 | Upgrade |
Other Financing Activities | 80.15 | 1.99 | 19.92 | -5 | -20 | 2 | Upgrade |
Financing Cash Flow | -452.38 | -390.15 | -328.81 | -236.41 | -552.75 | 358.69 | Upgrade |
Foreign Exchange Rate Adjustments | 20.08 | 13.85 | 7.55 | -102.64 | 11.93 | 8.7 | Upgrade |
Net Cash Flow | 56.56 | 190.68 | -113.21 | -159.85 | -639.08 | 1,059 | Upgrade |
Free Cash Flow | 565.96 | 554.64 | 137.02 | 751.68 | 84.16 | 1,193 | Upgrade |
Free Cash Flow Growth | 106.58% | 304.78% | -81.77% | 793.19% | -92.95% | 2840.91% | Upgrade |
Free Cash Flow Margin | 16.30% | 16.68% | 4.97% | 17.85% | 2.88% | 31.12% | Upgrade |
Free Cash Flow Per Share | 0.90 | 0.89 | 0.22 | 1.19 | 0.13 | 1.89 | Upgrade |
Cash Income Tax Paid | - | -133.35 | -10.34 | -94.58 | -5.2 | -129.72 | Upgrade |
Levered Free Cash Flow | 412.7 | 375.72 | -366.07 | 996.96 | -70.89 | 914.36 | Upgrade |
Unlevered Free Cash Flow | 421.72 | 391.68 | -346.15 | 1,019 | -60.15 | 925.39 | Upgrade |
Change in Working Capital | 69.3 | 69.3 | -66.82 | 192.57 | -152.67 | 224.48 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.